See how ZX Series Interactive Displays bring AI, collaboration, and Google-ready tools into classrooms, helping teachers ...
The American Institute of Personal Injury Attorneys independently selected DeSalvo for its 2026 10 Best Attorney ...
As 2026 begins, Java Burn reviews are once again climbing search results, not because of hype alone, but because ...
PURE: How 100% Kotton Is Redefining the Sound of Luxury House Music Miami, United States – March 30, 2026 / Kotton Grammer / FOR IMMEDIATE RELEASE Media Contact: Kotton Grammer / 100% Kotton Email: ...
India is launching cheap weight-loss drugs — but Novo Nordisk is betting its brands will stay on top
Novo lost semaglutide patent protection in India, triggering generic launches. Indian drugmakers launched generic versions at lower prices. Novo cut prices and used partnerships to defend market share ...
The weight-loss world is on the brink of a major shake-up. Pharmaceutical companies in India will get the green light this weekend to start selling generic versions of Ozempic and Wegovy, with several ...
In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster weight loss drug, opening the door for cheaper competing versions. By Rebecca ...
Semaglutide is part of a group of medicines called GLP-1 receptor agonists, commonly used to manage type 2 diabetes. In recent years, it has also gained worldwide attention for helping with weight ...
The FDA has approved a generic version of fluticasone propionate (marketed as Flovent HFA), according to a statement issued on March 3. The approval extends the accessibility of the medication, ...
Over the last year, Sanofi has been busy reshaping itself to focus more on innovative drugs, including selling a controlling stake in its former consumer business and using those proceeds to strike a ...
Muriel, from the Auxiliary of Social Life, works at the home of Mr. T, who has multiple sclerosis, in Pas de Calais, France, on June 11, 2023. (Astier / BSIP via AFP) (CN) — For people living with ...
New Jersey has joined 42 other states in suing global pharmaceutical company Novartis and its spin-off Sandoz for engaging in what they describe as “one of the most egregious examples of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results